Haematologica最新文献

筛选
英文 中文
Transcriptional landscape of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma: tumor microenvironment and checkpoint genes. 结节淋巴细胞为主的霍奇金淋巴瘤和富含t细胞/组织细胞的大b细胞淋巴瘤的转录景观:肿瘤微环境和检查点基因。
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-12 DOI: 10.3324/haematol.2026.301728
Ilja Kalashnikov, Veronica Russell, Rachel Kositsky, Leonardo P A Biral, Panu Kovanen, Johannes Dunkel, Marja-Liisa Karjalainen-Lindsberg, Annika Pasanen, Devang Thakkar, Jean L Koff, David Jaye, Sarah Ondrejka, Eric D Hsi, Emily F Mason, Ridas Juskevicius, Cassandra Love, Jennifer R Shingleton, Elizabeth Thacker, Lanie Happ, Clay Parker, Tushar Dave, Mette Ølgod Pedersen, Magdalena Czader, Jiehao Zhou, Dennis O'Malley, Mina Xu, Andrew Evans, Chee Leong Cheng, Matthew McKinney, Chad M McCall, Eric Tse, Rex Au Yeung, Yasodha Natkunam, Abner Louissaint, Jennifer Chapman, Catalina Amador, Amy Chadburn, Yuri Fedoriw, Amir Behdad, Carlos Galvez, Payal Sojitra, Andrew Evens, Kikkeri N Naresh, Sandeep S Dave, Sirpa Leppä
{"title":"Transcriptional landscape of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma: tumor microenvironment and checkpoint genes.","authors":"Ilja Kalashnikov, Veronica Russell, Rachel Kositsky, Leonardo P A Biral, Panu Kovanen, Johannes Dunkel, Marja-Liisa Karjalainen-Lindsberg, Annika Pasanen, Devang Thakkar, Jean L Koff, David Jaye, Sarah Ondrejka, Eric D Hsi, Emily F Mason, Ridas Juskevicius, Cassandra Love, Jennifer R Shingleton, Elizabeth Thacker, Lanie Happ, Clay Parker, Tushar Dave, Mette Ølgod Pedersen, Magdalena Czader, Jiehao Zhou, Dennis O'Malley, Mina Xu, Andrew Evans, Chee Leong Cheng, Matthew McKinney, Chad M McCall, Eric Tse, Rex Au Yeung, Yasodha Natkunam, Abner Louissaint, Jennifer Chapman, Catalina Amador, Amy Chadburn, Yuri Fedoriw, Amir Behdad, Carlos Galvez, Payal Sojitra, Andrew Evens, Kikkeri N Naresh, Sandeep S Dave, Sirpa Leppä","doi":"10.3324/haematol.2026.301728","DOIUrl":"https://doi.org/10.3324/haematol.2026.301728","url":null,"abstract":"<p><p>Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare B-cell malignancy with an indolent course, yet some cases relapse or transform to Tcell/ histiocyte-rich large B-cell lymphoma (THRLBCL). Biological factors underlying poor outcomes in NLPHL are largely unknown, and the relationship between THRLBCL and untransformed NLPHL has not been systematically defined. We analyzed 178 NLPHL and 22 THRLBCL cases using whole-transcriptome RNA sequencing and clinical data. NLPHL patients were younger, had limited-stage disease, and better outcomes than THRLBCL patients. Variant immuno-architectural patterns (IAP) in NLPHL showed THRLBCL-like transcriptional profiles, especially with splenic involvement and high Lymphocyte-Predominant International Prognostic Score (LP-IPS). In-silico deconvolution of the tumor microenvironment (TME) revealed B-cell enrichment in classic NLPHL, intermediate profiles in variant NLPHL, and increased activated CD4+ and CD8+ T-cells and macrophages in THRLBCL. Higher follicular helper T-cell content was associated with shorter event-free survival in an exploratory analysis. NLPHL cases showed strong B-cell and T-helper signatures, whereas THRLBCL cases were enriched for macrophage and cytotoxic T-cell pathways and expressed higher immune checkpoint genes, suggesting an immunosuppressive TME. Signatures defined a spectrum from classic to variant NLPHL and THRLBCL. External validation in independent cohorts reproduced this gradient, supporting a continuous microenvironmental spectrum spanning NLPHL and THRLBCL.</p>","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional DNase assessment in posttransplant lung injury. Comment on: "Neutrophil extracellular traps and DNase I levels in the bronchoalveolar lavage fluid of children with pulmonary injury after allogeneic hematopoietic stem cell transplantation: a TRANSPIRE study". 移植后肺损伤的功能dna酶评价。评论:“异基因造血干细胞移植后肺损伤患儿支气管肺泡灌洗液中中性粒细胞胞外陷阱和dna酶I水平:一项TRANSPIRE研究”。
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-12 DOI: 10.3324/haematol.2026.302282
Jiahuan Li, Wenya Li
{"title":"Functional DNase assessment in posttransplant lung injury. Comment on: \"Neutrophil extracellular traps and DNase I levels in the bronchoalveolar lavage fluid of children with pulmonary injury after allogeneic hematopoietic stem cell transplantation: a TRANSPIRE study\".","authors":"Jiahuan Li, Wenya Li","doi":"10.3324/haematol.2026.302282","DOIUrl":"https://doi.org/10.3324/haematol.2026.302282","url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome. 在多发性骨髓瘤阶段共享高风险转录程序与疾病进展和不良预后相关。
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-12 DOI: 10.3324/haematol.2026.301504
Claudio Cerchione, Nour Alassi, Delia Cangini, Sarah Tassinari, Asia Spedaluzzi, Irene Azzali, Sofia Cortesi, Giacomo Feliciani, Alice Rossi, Sonia Ronconi, Michela Ceccolini, Michela Tonelli, Gerardo Musuraca, Nicola Normanno, Emanuela Scarpi, Giorgia Simonetti, Giovanni Martinelli, Paul G Richardson, Matteo Marchesini
{"title":"Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome.","authors":"Claudio Cerchione, Nour Alassi, Delia Cangini, Sarah Tassinari, Asia Spedaluzzi, Irene Azzali, Sofia Cortesi, Giacomo Feliciani, Alice Rossi, Sonia Ronconi, Michela Ceccolini, Michela Tonelli, Gerardo Musuraca, Nicola Normanno, Emanuela Scarpi, Giorgia Simonetti, Giovanni Martinelli, Paul G Richardson, Matteo Marchesini","doi":"10.3324/haematol.2026.301504","DOIUrl":"https://doi.org/10.3324/haematol.2026.301504","url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comment on: "Risk factors and their contributions to prognosis in multiple myeloma". 对“多发性骨髓瘤的危险因素及其对预后的影响”评论的回应。
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-12 DOI: 10.3324/haematol.2026.302249
Tae-Hoon Chung, Jia Geng Chang, Tze King Tan, Wee Joo Chng
{"title":"Response to Comment on: \"Risk factors and their contributions to prognosis in multiple myeloma\".","authors":"Tae-Hoon Chung, Jia Geng Chang, Tze King Tan, Wee Joo Chng","doi":"10.3324/haematol.2026.302249","DOIUrl":"https://doi.org/10.3324/haematol.2026.302249","url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis. 胰高血糖素样肽-1受体激动剂暴露与慢性淋巴细胞白血病观察和等待期间继发恶性肿瘤风险降低相关:一项时变分析
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-12 DOI: 10.3324/haematol.2026.301905
Sigal Shaked, Lior Rokach, Ronen Arbel, Talish Razi, Tamar Tadmor
{"title":"Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis.","authors":"Sigal Shaked, Lior Rokach, Ronen Arbel, Talish Razi, Tamar Tadmor","doi":"10.3324/haematol.2026.301905","DOIUrl":"https://doi.org/10.3324/haematol.2026.301905","url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paraneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia. 副肿瘤海绵性皮炎与发展为需要治疗的慢性淋巴细胞白血病相关。
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-12 DOI: 10.3324/haematol.2026.301890
Tugce Guel, Simon Fietz, Emma Eichler, Natalija Novak, Ruth Flümann, Barbara Eichhorst, Michael Hallek, Matthias Zipfel, Joerg Wenzel, Jana Knuever
{"title":"Paraneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia.","authors":"Tugce Guel, Simon Fietz, Emma Eichler, Natalija Novak, Ruth Flümann, Barbara Eichhorst, Michael Hallek, Matthias Zipfel, Joerg Wenzel, Jana Knuever","doi":"10.3324/haematol.2026.301890","DOIUrl":"https://doi.org/10.3324/haematol.2026.301890","url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia. 特司他单抗治疗多发性骨髓瘤伴骨髓增生异常综合征或急性髓系白血病。
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-12 DOI: 10.3324/haematol.2026.301866
Regina Ferthio, Ximena Jordan Bruno, Alfred L Garfall, Adam D Cohen, Shivani Kapur, Catherine E Lai, Selina M Luger, Edward A Stadtmauer, Dan T Vogl, Adam Waxman, Sandra P Susanibar-Adaniya
{"title":"Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia.","authors":"Regina Ferthio, Ximena Jordan Bruno, Alfred L Garfall, Adam D Cohen, Shivani Kapur, Catherine E Lai, Selina M Luger, Edward A Stadtmauer, Dan T Vogl, Adam Waxman, Sandra P Susanibar-Adaniya","doi":"10.3324/haematol.2026.301866","DOIUrl":"https://doi.org/10.3324/haematol.2026.301866","url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct clinical and molecular profiles of acute myeloid leukemia defined by mutations in IDH1, IDH2, and TET2. 由IDH1、IDH2和TET2突变定义的急性髓系白血病的独特临床和分子特征
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-05 DOI: 10.3324/haematol.2026.301319
Fanny Asbaghi, Erik Håkansson, Jakob Hofvander, Yuhong Ning, Yuan Xue, Tierney Philips, Vladimir Lazarevic, Christer Nilsson, Sören Lehmann, Samuel Levy, Gunnar Juliusson, Ravindra Majeti, Niklas Landberg
{"title":"Distinct clinical and molecular profiles of acute myeloid leukemia defined by mutations in <i>IDH1</i>, <i>IDH2</i>, and <i>TET2</i>.","authors":"Fanny Asbaghi, Erik Håkansson, Jakob Hofvander, Yuhong Ning, Yuan Xue, Tierney Philips, Vladimir Lazarevic, Christer Nilsson, Sören Lehmann, Samuel Levy, Gunnar Juliusson, Ravindra Majeti, Niklas Landberg","doi":"10.3324/haematol.2026.301319","DOIUrl":"https://doi.org/10.3324/haematol.2026.301319","url":null,"abstract":"<p><p>Acute myeloid leukemia (AML) is a heterogeneous disease driven by recurring somatic mutations, frequently affecting genes involved in epigenetic regulation. Mutations in IDH1, IDH2, and TET2 are largely mutually exclusive and thought to converge on a shared pathway by impairing TET-mediated DNA demethylation, either directly through loss of TET2 activity or indirectly through the accumulation of the oncometabolite (R)-2-hydroxyglutarate (2-HG) in IDH1- and IDH2-mutant AML. Whether this biochemical convergence translates into similar disease biology remains unclear. Here, we analyzed AML defined by mutations in IDH1, IDH2, or TET2 using population-based data from the Swedish AML Registry, complemented by transcriptomic and 5-hydroxymethylcytosine (5hmC) profiling of purified blasts from a highly selected subset of primary AML samples. TET2-mutant AML occurred at an older age and was associated with a more pronounced thrombocytopenia, whereas IDH1- and IDH2-mutant AML showed deeper neutropenia and more favorable overall survival, including after adjustment for clinical covariates. Transcriptomic and 5hmC alterations showed only modest concordance, with 5hmC profiles providing clearer separation of the mutational subgroups. TET2-mutant samples showed significant enrichment of the oxidative phosphorylation pathway compared with IDH1- and IDH2-mutant AML. The mutational groups also showed distinct closest normal counterparts among healthy hematopoietic cell populations. Together, these findings demonstrate that IDH1, IDH2, and TET2 mutations define clinically and molecularly distinct subgroups of AML, highlighting the relevance of mutation-specific clinical stratification.</p>","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flow cytometric detection of the thymic stromal lymphopoietin receptor reliably identifies CRLF2-rearranged BCR::ABL1-like acute lymphoblastic leukemia. 流式细胞术检测胸腺基质淋巴生成素受体可靠地鉴定crlf2重排BCR:: abl1样急性淋巴细胞白血病。
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-05 DOI: 10.3324/haematol.2026.301773
Julian Liebaert, Martin Neumann, Lorenz Bastian, Claudia D Baldus, Monika Brüggemann, Stefan Habringer, Thomas Burmeister, Nicola Gökbuget, Ulrich Keller, Stefan Schwartz
{"title":"Flow cytometric detection of the thymic stromal lymphopoietin receptor reliably identifies <i>CRLF2</i>-rearranged <i>BCR</i>::<i>ABL1</i>-like acute lymphoblastic leukemia.","authors":"Julian Liebaert, Martin Neumann, Lorenz Bastian, Claudia D Baldus, Monika Brüggemann, Stefan Habringer, Thomas Burmeister, Nicola Gökbuget, Ulrich Keller, Stefan Schwartz","doi":"10.3324/haematol.2026.301773","DOIUrl":"https://doi.org/10.3324/haematol.2026.301773","url":null,"abstract":"","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD34+-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a large cohort study focusing on haploidentical transplantation. CD34+选择干细胞促进异体造血干细胞移植后移植物功能差:一项针对单倍体移植的大型队列研究
IF 8.2 1区 医学
Haematologica Pub Date : 2026-11-05 DOI: 10.3324/haematol.2026.301404
Yun He, Linwei Shi, Rui Ma, Tingting Han, Yao Chen, Yuanyuan Zhang, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Haixia Fu, Chenhua Yan, Meng Lv, Xiaodong Mo, Yifei Cheng, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Aiming Pang, Yuqian Sun
{"title":"CD34<sup>+</sup>-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a large cohort study focusing on haploidentical transplantation.","authors":"Yun He, Linwei Shi, Rui Ma, Tingting Han, Yao Chen, Yuanyuan Zhang, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Haixia Fu, Chenhua Yan, Meng Lv, Xiaodong Mo, Yifei Cheng, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Aiming Pang, Yuqian Sun","doi":"10.3324/haematol.2026.301404","DOIUrl":"https://doi.org/10.3324/haematol.2026.301404","url":null,"abstract":"<p><p>Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). CD34+-selected stem cell boost has shown promise; however, data in the haploidentical setting and after failure of thrombopoietin receptor agonists (TPO-RAs) are limited. Patients who received purified CD34+ boost for refractory PGF after HSCT at two centers were retrospectively analyzed. Outcomes included overall response rate (ORR), graft-versus-host disease (GVHD) and overall survival (OS). Among the 116 evaluable patients, 86.79% (103/116) received haploidentical transplants and 113 (97.4%) had received at least one platelet-stimulating agent, including TPO-RA and/or recombinant human thrombopoietin (rhTPO). The ORR was 67.24% (CR 62.93%, PR 4.31%). The 180-day cumulative recovery rates of neutrophils, hemoglobin, and platelets were 56.7%, 57.1%, and 65.7%, respectively. Active infection at the time of CD34+-selected stem cell boost was the sole independent predictor of lower ORR (OR = 3.786, 95% CI: 1.584-9.048, P = 0.003). The incidence of grade III-IV acute GVHD was 9.48%, and that of moderate-to-severe chronic GVHD was 11.21%. The OS was 64.66%. Responders had a significantly better OS than nonresponders (81.65% vs. 11.67%, P < 0.001). In conclusion, CD34+-selected stem cell boost is safe and highly effective for refractory PGF after allo-HSCT, including in haploidentical recipients and those who have failed TPO-RAs. Active infection at infusion predicts a poor treatment response, and non-responders have a dismal prognosis, underscoring the need for alternative strategies.</p>","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书